Welcome to our dedicated page for Innovative Eyewear SEC filings (Ticker: LUCYW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Innovative Eyewear, Inc. filings document the public-company record for the smart eyewear issuer and its Nasdaq-listed common stock and warrants, including LUCYW warrants to purchase common stock. Material-event reports cover equity offering activity, legal opinions related to share issuance, warrant inducement agreements, resale registration references, and shareholder director-nomination procedures.
Proxy materials describe annual meeting governance matters, board elections, auditor ratification, control-share voting-rights items, charter amendments, and rights-plan matters. The filings also identify capital-structure subjects such as common stock par value, registered warrants, warrant terms, and securities listed on The Nasdaq Stock Market.
Innovative Eyewear Inc (LUCY) is the issuer for a notice of proposed sale of securities under Rule 144 filed for officer Gayle Oswald. The notice covers up to 16,233 shares of common stock to be sold through Raymond James & Associates, Inc., arising from an RSU grant. Shares outstanding were 6,403,728 common shares as of 08/19/2026; this is a baseline figure, not the amount being sold.
Innovative Eyewear, Inc. reported strong top-line growth but continued losses for the quarter and six months ended June 30, 2026. Quarterly revenue was $1,010,519, up sharply from 2025 levels, driven mainly by Lucyd Armor smart safety glasses and Reebok-branded smartglasses across Lucyd.co, Amazon, and growing wholesale channels. Gross margin improved to 24%, compared with a small gross deficit a year earlier, as the company mitigated tariff impacts and benefited from better sourcing and scale.
Despite this, the company posted a quarterly net loss of $1,670,818 and a six‑month net loss of $3,980,186, reflecting ongoing spending on general and administrative, marketing, and product development. Cash and cash equivalents were $2.5 million, with total liquidity of about $3.7 million including U.S. Treasury bills, and working capital of roughly $6.2 million. Management expects liquidity to fund operations for at least 12 months, supplemented by a July 2026 warrant inducement that raised about $3.0 million before fees and an undrawn related‑party credit facility. However, disclosure controls and procedures were deemed ineffective due to material weaknesses in internal control over financial reporting.
Innovative Eyewear, Inc. is registering the resale of up to 6,766,673 shares of common stock, all issuable upon exercise of outstanding warrants held by selling stockholders. This includes 6,601,632 shares underlying Series J Investor Warrants exercisable at $1.10 per share and 165,041 shares underlying placement agent warrants exercisable at $1.6875 per share. The company will not receive proceeds from stockholder resales, but may receive cash if these warrants are exercised for cash, to be used for general corporate and working capital purposes.
The company develops and sells smart eyewear and related software, including Lucyd Lyte, Nautica, Eddie Bauer, Reebok and Lucyd Armor-branded products, and offers the Lucyd app with AI and communication features. As of July 22, 2026, 8,606,272 shares of common stock were outstanding; assuming full exercise of all Warrants, 15,372,945 shares would be outstanding. The common stock trades on Nasdaq under “LUCY,” with a last reported price of $0.68 per share on July 22, 2026. Innovative Eyewear qualifies as an emerging growth company and notes that investing in its securities involves a high degree of risk.
Innovative Eyewear, Inc. entered an inducement agreement with a warrant holder to immediately exercise 2,200,544 existing warrants at a reduced price of $1.35 per share, generating approximately $3.0 million in gross proceeds. In return, the company is issuing new unregistered Series J warrants to purchase up to 6,601,632 shares of common stock at an exercise price of $1.10 per share, exercisable immediately for 24 months after a future resale registration becomes effective. The company plans to use net proceeds for working capital and general corporate purposes, has engaged H.C. Wainwright & Co. as exclusive placement agent with cash fees and expense reimbursements, and will also issue placement agent warrants to buy 165,041 shares at $1.6875 per share.
Lucy Scientific Discovery Corp. filed a Section 144 notice relating to proposed sales of Common Stock. The filing includes a proposed sale quantity of 1,860 shares and reports shares outstanding were 6,400,000 as of 07/06/2026. The excerpt also shows an RSU grant of 18,200 shares dated 04/02/2026 and a reported sale by David Cohen of 1,860 shares on 04/09/2026.
Innovative Eyewear, Inc. reported strong top-line growth but continued losses for the quarter ended March 31, 2026. Revenue rose 70% year over year to $773,561, driven largely by higher unit volumes of its Lucyd Armor smart safety glasses and growing e-commerce sales on Lucyd.co and Amazon.
Despite this growth, the company posted a net loss of $2,309,368, or $0.37 per share, as operating expenses of $2,547,210 and a lower gross margin of 23% outweighed gains in revenue. General and administrative costs increased with higher professional services, compensation, and brand license fees, while sales and marketing spending remained roughly flat.
Cash and cash equivalents were $4.38M and total liquidity, including U.S. Treasury bill investments, was about $5.7M as of March 31, 2026, compared with $6.5M at year-end 2025. The company raised roughly $1.4M net through an at-the-market stock offering and believes existing liquidity plus a related-party credit facility can fund operations for at least 12 months, although it continues to report material weaknesses in internal control over financial reporting.
Innovative Eyewear, Inc. Schedule 13G/A reports that three related Reporting Persons — Mitchell P. Kopin, Daniel B. Asher and Intracoastal Capital LLC — may be deemed to beneficially own 699,295 shares of common stock, representing 9.99% of the class as of the close of business on March 31, 2026.
The filing states the 9.99% figure is calculated using 6,300,661 shares outstanding as of March 25, 2026 plus the 699,295 shares issuable upon exercise of a warrant held by Intracoastal ("Intracoastal Warrant 1"). The filing explains multiple warrants contain blocker provisions that limit exercise to avoid exceeding 9.99% or 4.99% ownership caps; without those blockers the Reporting Persons could be deemed to beneficially own 2,266,741 shares.